Resolutions from Annual General Meeting in NeuroVive Pharmaceutical AB (publ)
Lund, Sweden, 25 April 2019, NeuroVive Pharmaceutical AB(Nasdaq Stockholm: NVP, OTCQX: NEVPF) today on 25 April 2019 held its Annual General Meeting (AGM). A summary of the resolutions follows.Approval of income statements and balance sheets, and discharge from liability of the board members and the managing directorThe income statements and balance sheets were approved, and the managing director and the board members were discharged from liability with respect to their respective management of the company for the financial year 2018. DividendIn accordance with the Board of Directors'